Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
00512 GRAND PHARMA
RT Nominal up9.490 +0.090 (+0.957%)
Ranking Overview
Buy
Ranking based on 2 research report(s)
Average Ranking 2.00
0
2
0
0
0
Previous Financial Performance
Financial Year 12/2024 EPS 70.49 HKD (cts)
Net Profit 2,468.38 HKD (MIL) DPS 26.00 HKD (cts)
Consolidation Estimation
Financial Year Profit / (Loss)
(HKD (MIL))
EPS/
((LPS)(HKD (cts))
DPS
(HKD (cts))
Net Asset Value per Share
(HKD)
Highest
(HKD (MIL))
Lowest
(HKD (MIL))
20252,125.5060.0023.93--2,131.002,120.00
20262,284.5064.5025.65--2,334.002,235.00
20272,681.0076.0030.18--2,681.002,681.00
Profit Estimation
Profit Estimation Profit / (Loss)
(HKD (MIL))
EPS*/
(LPS) (HKD (cts))
DPS *
(HKD (cts))
Broker Ranking Target Price*
(HKD)
Update Date
20252,120.0060.0023.86HUATAI FIN HLDGS HKBuy10.15 19/05/2025
20252,131.0060.0024.00CICCOutPerform9.60 13/05/2025
 
20262,334.0066.0026.30HUATAI FIN HLDGS HK----19/05/2025
20262,235.0063.0025.00CICC----13/05/2025
 
20272,681.0076.0030.18HUATAI FIN HLDGS HK----19/05/2025
Remarks:  Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa.
  *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue
  Real time quote last updated: 23/07/2025 09:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service